// App-Quantinova.ai

3165 : An evidence-based software tool for personalized cancer medicine to recommend therapeutic options and avoid toxicity

Researchers

Presenter

  • Matthias Lohr

Principal Investigators

  • Caroline Huelsewig

  • Sandra Morandell

  • Isin Ertongur

  • Sarah Luke-Glaser

  • Anna Laib

  • Linnea Malgerud

  • Carlos Fernandez Moro

  • Masoud Karimi

  • Johan Permert

  • Rainer Heuchel

  • Johan Lindberg

  • Valtteri Wirta

  • Alexander Picker

  • Marco Del Chiaro

  • Stephan L. Haas

  • Caroline S. Verbek

  • Lars Engstrand

  • Jens Siveke

  • David Jackson

  • Henrik Gronberg

  • Dirk Jager

  • Stephan Brock

Medical Centers

  • Center for Digestive Diseases, Stockholm, Sweden

  • Molecular Health, Heidelberg, Germany

  • Department of Oncology, Karolinska University Hospital, Stockholm, Sweden

  • Dept. of Oncology at Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden

  • Innovation Office, Karolinska University Hospital, Stockholm, Sweden

  • Dept of Clinical Sciences, Intervention and Technology (CLINTEC), Karolinska Institute, Stockholm, Sweden

  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

  • Science for Life Laboratory, Stockholm, Sweden

  • Rainer Herzog Comprehensive Cancer Center (RHCCC), Technical University, Munich, Germany

  • National Center for Tumors (NCT), Heidelberg, Germany.

Locations

  • Germany

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Methadone hydrochloride

Outcome

  • N/A

Study Design

  • Controlled

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved